ArticleInternational journal of women's health2026
Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer: A Multicenter Real-World Study.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the controversial impact of lymphadenectomy on prognosis and postoperative complications in patients with advanced epithelial ovarian cancer (AEOC) receiving neoadjuvant chemotherapy followed by interval debulking surgery (IDS). Methods: This retrospective real-world study analyzed 1068 patients with AEOC undergoing IDS at seven tertiary centers in China between 2006 and 2021. Endpoints included progression-free survival (PFS), overall survival (OS), and postoperative complications. Propensity score matching (PSM) and overlapping weight (OW) analyses were employed to minimize selection bias. Results: Of the cohort, 528 patients (49.4%) underwent lymphadenectomy. After adjustment, 960 patients were matched in the propensity score matching cohort (480 per group), and 1068 patients were included in the overlapping weight cohort. Lymphadenectomy was consistently associated with improved PFS in the unadjusted (HR, 0.77; 95% CI, 0.67-0.90; Conclusion: In this multicenter retrospective cohort study, lymphadenectomy during IDS was associated with improved PFS but not OS after adjustment. No increased risk of postoperative complications was observed. Given the retrospective design, prospective studies are needed to validate these findings and clarify the role of lymphadenectomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.